期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
祛湿健骨方对MC3T3-E1细胞成骨分化能力的促进作用研究
1
作者 刘阗生 热孜亚·艾买提 +3 位作者 阿衣努尔·热合曼 陈媛鑫 卡依沙尔 阿衣努尔·买提斯迪克 《新疆医科大学学报》 CAS 2024年第3期426-429,446,共5页
目的探讨祛湿健骨方对MC3T3-E1细胞的作用机理。方法将祛湿健骨方配成不同浓度溶液(0.005、0.025、0.05、0.1、0.2、0.4 mg/mL),用不同浓度祛湿健骨方对细胞进行干预,干预48 h后,采用CCK-8法检测细胞增殖率,筛选最佳药物浓度。将MC3T3-E... 目的探讨祛湿健骨方对MC3T3-E1细胞的作用机理。方法将祛湿健骨方配成不同浓度溶液(0.005、0.025、0.05、0.1、0.2、0.4 mg/mL),用不同浓度祛湿健骨方对细胞进行干预,干预48 h后,采用CCK-8法检测细胞增殖率,筛选最佳药物浓度。将MC3T3-E1细胞制成细胞悬液,随机分为对照组、地塞米松组、低剂量组、中剂量组、高剂量组,接种至六孔板。待细胞贴壁达到80%后进行造模(对照组不添加药物;地塞米松组使用地塞米松干预;低剂量组、中剂量组、高剂量组分别用相应浓度的祛湿健骨方+地塞米松进行干预)48 h后更换为成骨诱导培养基进行培养。诱导15 d后,测定各组细胞的碱性磷酸酶(Alkaline phosphatase,ALP)含量和Runt相关转录因子2(Runt-related transcription factor 2,RUNX2)、骨细胞特异性转录因子(Osterix,OSX)蛋白的表达量。结果经CCK-8实验结果对比,药物筛选前3位存活率浓度为0.1 mg/mL(低浓度)、0.2 mg/mL(中浓度)、0.4 mg/mL(高浓度)。与对照组相比,地塞米松组、低剂量组、中剂量组、高剂量组细胞ALP活性均降低差异有统计学意义(P<0.05);与地塞米松组相比,低剂量组、中剂量组差异无统计学意义(P>0.05),高剂量组细胞ALP活性升高,差异有统计学意义(P<0.05)。与对照组比较,中剂量组、低剂量组、地塞米松组细胞的RUNX2、OSX蛋白表达均降低,差异有统计学意义(P<0.05),高剂量组细胞OSX和RUNX2蛋白表达差异无统计学意义(P>0.05);与地塞米松组比较,高剂量组OSX和RUNX2蛋白表达差异均有统计学意义(P<0.05)。结论祛湿健骨方能够促进MC3T3-E1细胞的成骨分化能力,其可能是通过调节RUNX2、OSX等骨形成相关蛋白,以此纠正骨形成与骨吸收的平衡,达到治疗骨质疏松症的作用。 展开更多
关键词 MC3T3-E1细胞 骨质疏松症 成骨分化
下载PDF
Ela tablets improve sexual performance in mice with erectile dysfunction caused by repeated restraint stress
2
作者 Zeyu Gao Jun Chen +6 位作者 ayinuer reheman Yi Sun Tao Wu Xirali Tursun Xiaoping Pu Haji Akber Aisa Xin Zhao 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第11期883-894,共12页
Ela tablets contain an optimized extract of a Chinese herbal prescription. The original prescription has been used to treat erectile dysfunction(ED), while the detailed indications and specific treatment mechanisms of... Ela tablets contain an optimized extract of a Chinese herbal prescription. The original prescription has been used to treat erectile dysfunction(ED), while the detailed indications and specific treatment mechanisms of Ela tablets remain unclear. In the present study, we aimed to investigate whether Ela tablets could protect mice from ED caused by repeated restraint stress and to explore the possible mechanisms. Mice were restrained daily in centrifuge tubes with venting holes for 14 consecutive days and administered Ela tablets at 1 h before restraining. On the 14 th night, mating experiments were conducted. Thereafter, blood, testicular, and penile samples were collected. Serum testosterone levels were measured using a kit. Testicular tissue morphology was observed by H&E staining. The PDE5 expression in the corpus cavernosum was measured by Western blotting analysis. The results indicated that Ela tablets significantly shortened the sexual arousal time, increased the number of sexual encounters, maintained the normal morphology of testicular tissue, increased the serum testosterone levels, and decreased the PDE5 expression in the corpus cavernosum. Our data showed that Ela tablets elicited protective effects on the sexual ability of mice exposed to repeated restraint stress. Moreover, the underlying mechanism was related to the preservation of testicular tissue morphology, maintenance of testosterone levels, and inhibition of penile PDE5 expression. 展开更多
关键词 Ela tablets Erectile dysfunction Repeated restraint stress
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部